Insider Transactions by Heberlig Chris

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
GEVASYNAGEVA BIOPHARMA CORPHeberlig ChrisSVP, Finance & Business Ops.Jun 22, 2015Option Exercise$78.87564,41724,446Jun 23, 2015, 10:33 AM
GEVASYNAGEVA BIOPHARMA CORPHeberlig ChrisSVP, Finance and Business Ops.Mar 11, 2015Sale$71.9815,0861,085,9027,890Mar 13, 2015, 05:49 PM
GEVASYNAGEVA BIOPHARMA CORPHeberlig ChrisGroup Vice President, FinanceDec 29, 2014Sale$55.1512,200672,8416,404Dec 30, 2014, 04:49 PM
GEVASYNAGEVA BIOPHARMA CORPHeberlig ChrisGroup Vice President, FinanceJun 30, 2014Option Exercise$54.891126,148304Jul 02, 2014, 05:56 PM
GEVASYNAGEVA BIOPHARMA CORPHeberlig ChrisGroup Vice President, FinanceMar 12, 2014Sale$57.0315,340874,9167,862Mar 14, 2014, 04:07 PM
GEVASYNAGEVA BIOPHARMA CORPHeberlig ChrisGroup Vice President, FinanceDec 31, 2013Option Exercise$36.301926,970192Jan 02, 2014, 07:07 PM
GEVASYNAGEVA BIOPHARMA CORPHeberlig ChrisVice President, FinanceJul 15, 2013Option Exercise$8.953,01927,0272,524Jul 17, 2013, 04:21 PM
GEVASYNAGEVA BIOPHARMA CORPHeberlig ChrisVice President, FinanceJul 16, 2013Sale$48.262,02997,9200Jul 17, 2013, 04:21 PM
GEVASYNAGEVA BIOPHARMA CORPHeberlig ChrisVice President, FinanceDec 19, 2012Sale$23.448,000187,5054,000Dec 21, 2012, 03:45 PM
GEVASYNAGEVA BIOPHARMA CORPHeberlig ChrisVice President, FinanceOct 17, 2012Option Exercise$25.498,000203,9204,000Oct 19, 2012, 05:10 PM
GEVASYNAGEVA BIOPHARMA CORPHeberlig ChrisVice President, FinanceSep 04, 2012Sale$25.022,00050,0501,000Sep 06, 2012, 05:00 PM
GEVASYNAGEVA BIOPHARMA CORPHeberlig ChrisVice President, FinanceJun 01, 2012Sale$18.342,00036,6831,000Jun 05, 2012, 05:10 PM
GEVASYNAGEVA BIOPHARMA CORPHeberlig ChrisVice President, FinanceFeb 27, 2012Option Exercise$18.929,000170,2354,500Feb 29, 2012, 09:27 AM